| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.8M | +291.5% |
| Cost of Revenue | $48.3M | — |
| R&D Expense | $155.7M | +15.1% |
| SG&A Expense | $81.6M | +41.5% |
| Operating Income | -$245.7M | -34.4% |
| Interest Expense | $55K | -98.1% |
| Income Tax | $0 | — |
| Net Income | -$239.5M | -28.4% |
| EPS (Basic) | -$1.36 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $549.9M | +92.9% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $569.8M | +6.6% |
| Total Assets | $701.3M | +14.9% |
| Current Liabilities | $100.3M | +114.9% |
| Total Liabilities | $215.5M | +219.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83.5M | +47.3% |
| Capital Expenditures | $37.1M | -6.9% |
| Investing Cash Flow | $193.2M | +171.1% |
| Financing Cash Flow | $154.3M | -66.3% |
| Free Cash Flow | -$120.6M | +39.2% |
| +8.7% |
| EPS (Diluted) | -$1.36 | +8.7% |
| Stockholders' Equity |
| $485.8M |
| -10.5% |